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immunological reagents has so far limited their use in host response studies. Using recently established real-
time PCR assays for a panel of ferret cytokines, we analyzed the local ferret immune response to human
inﬂuenza isolates of the H1N1 and H3N2 subtypes that varied in their virulence.We observed that the severity
of clinical signs correlated with gross- and histopathological changes in the lungs and was subtype-
independent. Strains causing a mild disease were associated with a strong and rapid innate response and
upregulation of IL-8, while severe infections were characterized by a lesser induction of type I and II
interferons and strong IL-6 upregulation. These ﬁndings suggest that more virulent strainsmay interfere more
efﬁciently with the host response at early disease stages.






Human seasonal inﬂuenza strains
Innate immune response inhibitionIntroduction
Seasonal inﬂuenza A causes an acute respiratory infection with
high morbidity and considerable mortality, mostly in the very young
and the elderly (Treanor, 2007). The disease is characterized by a
sudden onset of malaise and fever, followed by upper and sometimes
lower respiratory signs of disease, myalgia, and headache (Cate, 1987;
Wright et al., 1980). Systemic disease manifestations subside once the
virus is cleared, usually within three to ﬁve days after infection, but
respiratory signs including coryza and cough may persist longer
(Wright et al., 1980). Severe disease and mortality occur preferentially
in immunocompromised patients and individuals with pre-existing
lung disease, and are often due to secondary bacterial infections
(Whitley and Monto, 2006).
Infection with seasonal inﬂuenza in humans rapidly induces a
cascade of pro-inﬂammatory cytokines including type I interferons
(IFN), tumor necrosis factor (TNF)α, and interleukins (IL)-6 and -8
(Gentile et al., 1998; Hayden et al., 1998). Human volunteer studies have
shown a direct correlation between disease severity, the extent of viral
replication in the upper respiratory tract, and the levels of these
cytokines in nasal wash ﬂuids and plasma (Eccles, 2005; Kaiser et al.,
2001). This innate immune response is in large part responsible for virus
control and clearance, as antibodies and speciﬁc Tcells are ﬁrst detected
around four days after infection, when the virus titer is alreadyier, University of Quebec, 531
0 686 5305.
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l rights reserved.decreasing (Graham and Braciale, 1997). In the case of infections with
highly pathogenic inﬂuenza strains, this cytokine response becomes
dysregulated, resulting in the “cytokine storm” observed in recentH5N1
fatalities (de Jong et al., 2006; Kobasa et al., 2007).
Ferrets are traditionally used to study inﬂuenza because they are
naturally susceptible to the virus (Maher and DeStefano, 2004). When
infected with the same strain, ferrets show a similar disease pattern to
humans (Smith and Sweet,1988). They also sharemarked similarities to
humans in terms of lung physiology, airway morphology and cell types
present in the respiratory tract, including the distribution of α-2,6-
linked sialic acids, the receptor for human inﬂuenza viruses (Plopper
et al., 1980; van Riel et al., 2007). The model is regularly used for the
production of highly speciﬁc antisera (Kendal et al., 1982), the assess-
ment of virulence and transmissibility of individual isolates (Govorkova
et al., 2005; Herlocher et al., 2001; Zitzow et al., 2002), and vaccine or
drug efﬁcacy studies (Hoffmann et al., 2005; Mishin et al., 2005; Sweet
et al., 2002). However, its application to the characterization of the
immune response contribution to inﬂuenza pathogenesis has been
limited by the lack of ferret-speciﬁc reagents.
We have recently cloned and sequenced a panel of ferret cytokines
and established semi-quantitative RT-PCRs, enabling us to generate
cytokine proﬁles from different cell types (Svitek and von Messling,
2007). To identify immune correlates of disease severity, we infected
ferrets with human H1N1 and H3N2 isolates that differed in their
virulence. Animals inoculated with the more virulent strains required
more time to clear the virus and experienced more severe gross- and
histopathological changes in the lung. When analyzing cytokine
mRNA levels in cells from nasal wash ﬂuid, we observed that severe
infections resulted in a delayed and overall reduced IFN response and
Fig. 2. Gross pathological changes in the lungs of animals infected with the different
inﬂuenza strains. Two animals of each group were sacriﬁced four days after infection.
The lungs were removed and photographed using the Macro-Illumination Imaging
System (Lightools, Encinitas, CA). A dorsal view of a representative lung is shown for
each virus.
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the efﬁciency of the innate immune response in controlling the virus
contributes to disease severity. Furthermore, we show for the ﬁrst
time that the ferret cytokine response to inﬂuenza reproduces key
ﬁndings from human volunteer studies, thus extending the model to
host response studies.
Results
Delayed clearance of more virulent strains from the upper respiratory tract
To compare the cytokine proﬁle associated with mild and severe
inﬂuenza in ferrets, we chose the following four viruses based on their
subtype and virulence: the H1N1 strains PR/34 and USSR/77, and the
H3N2 strains Aichi/68 and PC/73. For each virus, groups of six animals
were inoculated intranasally with 105 TCID50. PR/34 consistently
caused a fever peak 24 h after infection, whereas animals infectedwith
the other viruses experienced the highest temperature two days post
infection (Fig. 1A). Clinically, PR/34 and Aichi/68 had no effect on body
weight and caused only short-lived mild respiratory disease char-
acterized by occasional sneezing and little serous nose exudates, and a
small and transient reduction in activity levels. In contrast, USSR/77
and PC/73 were associated with a transient weight loss, depression,
and frequent sneezing, coughing andmucous to purulent nose exudate
for at least three days (Figs. 1B and C). With the exception of Aichi/68,
which replicated more than tenfold less efﬁcient in the upper
respiratory tract, all viruses reached similar nasal wash titers during
the ﬁrst two days after infection (Fig. 1D). However, the more virulent
strains, USSR/77 and PC/73, resulted in higher titers at later infection
stages and delayed clearance.
More virulent strains cause more severe lung pathology
In an initial study with USSR/77, we had observed that gross-
pathological changes in the lungs were ﬁrst notable at day two afterFig. 1. Pathogenesis and virulence of different inﬂuenza strains. (A) Body temperature, (B) b
log10 tissue culture infectious doses (TCID50) over the ﬁrst six days of the disease. Groups of
USSR/77 and PR/34 are represented by black or gray circles, those infected with the H3N2 su
the X axis, percent body weight change, clinical score, body temperature, or nasal wash vir
respiratory signs of disease scores, each graded on a 0–1–2 scale. Error bars represent the sinfection, peaked at day four, receded at day six, and were completely
resolved at day fourteen, thus closely corresponding to the clinical
course of disease (data not shown). To investigate the impact of the
different viruses on the lower respiratory tract, we therefore sacriﬁcedody weight change, (C) clinical scores, and (D) nasal wash virus titers expressed as 50%
six animals were infected with each virus. Animals inoculated with the H1N1 subtypes
btypes PC/73 and Aichi/68 by black or gray squares. Days post-infection are indicated on
us titer are plotted on the Y axis. The clinical score represents the sum of activity and
tandard deviation.
Fig. 3. Histopathological changes in the lung caused by the different viruses. The images shown are hematoxylin-and-eosin-stained sections of upper right lung lobes of ferrets
inoculated with PR/34, Aichi/68, USSR/77, or PC/73 and sacriﬁced four days after infection or a mock-infected control animal at 200× magniﬁcation. Black arrows indicate edema.
55N. Svitek et al. / Virology 376 (2008) 53–59two animals of each group four days after infection. Macroscopically,
the mild strains were associated with few localized changes, mostly
located in the upper lung lobes (Fig. 2, top panels), while the more
virulent strains caused large areas of red hepatization throughout the
lung (Fig. 2, bottom panels). Only discrete histopathological changes,
mostly thickening of the alveolar membranes consistent with mildFig. 4. Immunohistochemical detection of inﬂuenza infection in the lung. (A, B) Sections of US
stained with an inﬂuenza-speciﬁc polyclonal goat antibody and counterstained with hematinterstitial pneumonia were detected in the lungs of animals infected
with PR/34 or Aichi/68 (Fig. 3, compare upper control panelwith PR/34
and Aichi/68 panels). In contrast, USSR/77 and PC/73 caused a more
severe swelling of the alveolar membranes, inﬁltration of mixed
inﬂammatory cells, and occasional edema (Fig. 3, compare upper
control panel with USSR/77 and PC/73 panels). All viruses resulted inSR/77-infected and (C, D) PC/73-infected animals sacriﬁced four days post infectionwere
oxylin. 400× magniﬁcations are shown.
56 N. Svitek et al. / Virology 376 (2008) 53–59the partial loss of the epithelial layer in smaller bronchi, but increased
damage and inﬂammation on the bronchiolar level were rarely
observed (Fig. 3, lower panels).
Infection and inﬂammatory response in the lung do not co-localize at the
peak of macroscopic damage
To evaluate whether histopathological changes represent sites of
active virus infection, we stained lung sections immunohistochemi-
cally for the presence of inﬂuenza antigen. Little infectionwas found in
tissues from PR/34- and Aichi/68-infected animals (data not shown),
whereasmultiple infected foci were detected throughout USSR/77 and
PC/73-infected lung sections (Figs. 4B and D, respectively). Within the
tissue, the infection was mostly found in cells with epithelial
characteristics in areas that showed little morphological changes and
no inﬂux of inﬂammatory cells, while areas with prominent pathology
were free of virus (Fig. 4, compare panels A and B, and C and D).
Mild disease is associated with a strong and rapid local cytokine response
When determining the cell count of the nasal wash ﬂuid, we
observed a ten- to hundred-fold increase of viable cells within 24 h after
infection with inﬂuenza, regardless of the strain used. The majority of
these cells had epithelial characteristics, but cells with leukocyte
morphology were also consistently detected (data not shown). To
characterize the local immune response during the early infection
stages, we isolated RNA from these cells and generatedmRNAproﬁles of
IFNα, IFNγ, TNFα, and the pro-inﬂammatory cytokines IL-6 and IL-8.
The two strains that caused only mild disease, PR/34 and Aichi/68,
elicited a rapid and strong upregulation of IFNα, IFNγ, and TNFα, while
both more virulent strains induced signiﬁcantly lower levels of IFNα
during the ﬁrst two days after infection, and the expression of IFNγ
and TNFα was delayed, particularly in the case of PC/73 (Fig. 5, top
panels). During the ﬁrst four days after infection, IL-6 was only
detected in samples from animals inoculated with the more virulent
viruses, whereas IL-8 expression was associated with mild disease
(Fig. 5, bottom panels).Fig. 5. Comparison of cytokine responses in animals infected with mild or severe inﬂuenza s
nasal wash ﬂuids was used in each reaction. Each sample was analyzed in duplicates and rep
subtypes USSR/77 and PR/34 are represented by black or gray circles, those infected with the
average of three to six animals, and error bars indicate the standard deviation. Stars indicate a
connected by lines. P values were calculated by individually comparing the different groupsDiscussion
Inﬂuenza infection triggers a cascade of host defenses that is
responsible for many of the symptoms associatedwith the disease, but
also for virus control and clearance. Human volunteer studies with
seasonal inﬂuenza viruses have shown that the infection resulted in
rapid activation of the innate immune response, and that symptoms
and fever correlated with the extent of IL-6 release (Gentile et al.,
1998; Hayden et al., 1998). To characterize the contribution of the
immune response to inﬂuenza disease severity in more detail, we
compared the mRNA levels of a cytokine panel representative for
innate immune activation in nasal wash cells from ferrets infected
with H1N1 and H3N2 subtypes that differ in their virulence.
Ferrets reproduce the human cytokine response to inﬂuenza
Inﬂuenza causes similar pathological changes and disease course in
humans and ferrets (Smith and Sweet,1988), but it is unknown if these
similarities extend to the innate and cellular immune response. In this
study, we observed a strong induction of type I and II IFNs and TNFα
regardless of the virus used, which is consistent with the previously
published ﬁndings from human volunteer studies and mouse experi-
ments (Brydon et al., 2005). In addition, we found that IL-6, which is
considered indicative of severe disease in humans (Kaiser et al., 2001;
Skoner et al., 1999), was only induced in the context of an infection
with more virulent strains, while early IL-8 expression was associated
with viruses that caused only mild disease. IL-8 is primarily produced
by epithelial and endothelial cells and tissue macrophages to attract
neutrophils to sites of tissue damage. In experimental inﬂuenza
infections of pigs and humans, IL-8 secretion has beenmainly detected
at later disease stages and in temporal association with inﬁltration of
the respiratorymucosa (Hayden et al.,1998; Van Reeth, 2000). The IL-8
induction we observed in PR/34- and Aichi/68-infected animals may
thus be indicative of rapid, granulocyte-mediated virus clearance and
infection control in the upper respiratory tract. Although it is
conceivable that variations in the composition of the nasal wash cells
contribute to the observed differences in the cytokine proﬁles, ourtrains over the ﬁrst four days after infection. 10 ng of RNA isolated from cells present in
eated twice more if the variation was more than 10%. Animals inoculated with the H1N1
H3N2 subtypes PC/73 and Aichi/68 by black or gray squares. Each value represents the
P value of b0.05 for the marked data point compared to all others, or for the data points
at the indicated time points with an unpaired, two-tailed Students t test.
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experimental infections in other species (Hayden et al., 1998; Kaiser
et al., 2001), thereby demonstrating the value of the ferret model for
the study of the host response to inﬂuenza.
Inﬂuenza virulence and cytokine response are subtype-independent
The viruses included in our study belonged to the H1N1 and H3N2
subtypes, which are currently circulating in the human population, and
were not directly genetically related. USSR/77 caused an inﬂuenza
epidemic in 1977/78 that resulted in the reintroduction of the H1N1
subtype in the human population (Kilbourne, 2006), and PC/73
represents a typical H3N2 isolate. We found that both viruses caused a
severe acute respiratory infection and widespread lung pathology
conﬁrming the similarity between ferrets and humans with respect to
disease course andpathology (Rareyet al.,1987; Smith andSweet,1988).
The reason for the low virulence of Aichi/68, which is an early H3N2
isolate (Verhoeyen et al., 1980), remains unknown,while the attenuated
phenotype of PR/34 is most likely due tomutations accumulated during
mouse adaptation (Grimm et al., 2007). It was recently shown that the
PR/34 NS1 protein, in contrast to other H1N1 NS1 proteins, is unable to
block post-transcriptional processing of cellular mRNAs, while main-
taining its IFN antagonistic activity (Kochs et al., 2007). This defect could
explain our observation that PR/34 causes only mild disease despite its
efﬁcient replication in the upper respiratory tract. In this context, the
fever peak within 24 h after infection would be the consequence of an
immediate immune recognition of the initially infected cells.Overall, the
direct comparison of these strains in ferrets clearly demonstrates that
the severity of clinical signs and histopathological changes correlate
with the cytokine response elicited, regardless of the strain's subtype.
Seasonal inﬂuenza disease — a combination of virus-induced damage
and immunopathology?
Since ferrets survive the infection with seasonal inﬂuenza strains,
thismodel enables us to characterize the contributions of virus infection
and host response to pathological changes in the context of non-lethal
infections (Maher and DeStefano, 2004). While mild disease-causing
strains resulted in little lung pathology, we were initially surprised by
the extent of gross-pathological damage associated with the more
severe strains. The limited amount of viral antigen detected in these
tissues, in combinationwith the lack of co-localization of infectionwith
areas of histopathological damage, indicate that, in the process of
clearing the virus, the immune response contributes importantly to
inﬂuenza-induced lung pathology even in the context of non-highly
pathogenic strains. Even though the cytokine levels in nasal wash cells
provide only limited insight in state of immune activation in the lung,
the detection of the pro-inﬂammatory cytokine IL-6 only in animals
infected with the more virulent strains further supports this interpreta-
tion. Studies in transgenic mice lacking different cytokines, and case
reports of fatal human H5N1 infections have clearly established the link
between an exaggerated inﬂammatory response and poor disease
outcome in the context of highly pathogenic inﬂuenza (Dawson et al.,
2000;de Jonget al., 2006; Schmitz et al., 2005).Our studysuggests that a
milder form of this immunopathology may play an important role in
severe seasonal inﬂuenza disease.
More virulent strains interfere more efﬁciently with the innate immune
response
There is an increasing body of evidence from in vitro experiments
and mouse models that inﬂuenza has developed multiple mechan-
isms to counteract host response activation (Grimm et al., 2007; Kochs
et al., 2007). Even highly pathogenic inﬂuenza in macaques was
associated with a delay in IFNα and IL-8 upregulation, suggesting an
initial inhibition of the host response (Kobasa et al., 2007). In ourstudy, animals infected with viruses that caused a mild disease
induced the expression of type I and II interferons more rapidly and to
higher levels than those infected with more virulent strains. Since
virus replication peaks 24–48 h after infection, the observed delay is
likely sufﬁcient to enable spread to the lower respiratory tract, which
results in more severe disease. Our study thus provides clear evidence
of inﬂuenza-mediated immune response inhibition in an outbred
animalmodel that closely reproduces the human disease. In summary,
the work presented here suggests that the ability of an individual
strain to interfere with the early host response contributes to its
virulence once the virus has adapted to humans.
Materials and methods
Viruses and cells
Viruseswere propagated and titrated inMDCK cells (ATCCCCL-34) in
Dulbecco's modiﬁed Eagle's medium (DMEM, Invitrogen) in the
presence of 2 μg/ml TPCK-trypsin (Sigma), and 1% fetal bovine serum
(FBS, Invitrogen) were added prior to virus stocks at the time of harvest.
The cells were maintained in DMEM with 5% FBS. All viruses were the
generous gift of Jit Arora. The strain H1N1 A/USSR/90/77 (USSR/77) was
ampliﬁed directly from a CDC seed stock vial, the strains H3N2 A/Port
Chalmers/1/73 (PC/73) and A/Aichi/2/68 (Aichi/68) had been passaged
in embryonated eggs once or 39 times, respectively, and the strainH1N1
A/Puerto Rico/8/34 (PR/34) originated from laboratory stock of
unknown passage history. The identity of Aichi/68 was conﬁrmed by
sequence analysis of the NP and M genes, ampliﬁed following the
protocol outlined in (Hoffmann et al., 2001). The vaccine reassortants
H1N1 A/New Caledonia/20/99 and H3N2 A/Wisconsin/67/2005 were
used for serological evaluation of the animals used. Virus titers were
determined by limited dilution and expressed as 50% tissue culture
infectious doses (TCID50).
Animal experiments
Four to six months old male ferrets were purchased from Marshall
Farms (North Rose, New York). After one week of acclimatization, a
serum sample was collected and analyzed for the presence of
neutralizing antibodies against the vaccine reassortants H1N1 A/New
Caledonia/20/99 and H3N2 A/Wisconsin/67/2005, which were part of
the inﬂuenza vaccine in the 2006/7 season, as well as the respective
strain to be studied using the microneutralization assay previously
described for canine distemper (vonMessling et al., 1999). Only animals
without neutralizing antibodies were included in the study. Groups of
six animals were anesthetized by intramuscular injection of ketamine
(25 mg/kg, CDMV) and midazolam (1.25 mg/kg, CDMV) and infected
intranasally with 105 TCID50 in 200 μl OptiMEM (Invitrogen) of the
respective virus.
Body temperature, activity, and respiratory signs were assessed
daily, and the animals were weighed every second day. The activity
evaluation involved the observation of the animal in the cage and
during investigator-initiated play outside the cage, and was graded on
a 0–1–2 scale, with 0 representing normal activity levels and
playfulness,1 representing calm demeanor and reduced play episodes,
and 2 representing depression and loss of interest in playing.
Respiratory signs were also graded on a 0–1–2 scale, with 0
representing the normal state, 1 representing occasional sneezing
and serous nose exudates, and 2 representing frequent sneezing,
coughing, and mucous nose exudate. The disease score is expressed as
the sum of activity and respiratory disease scores.
Nasal washes were collected every day for the ﬁrst four days and
every second day thereafter. Towards this, 500 μl of phosphate-
buffered saline (PBS, Invitrogen) was instilled in one nostril and the
expectorate was collected in 50 ml centrifuge tubes. The procedure
was repeated twice to obtain a minimal volume of 400 μl. Viable cells
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counted, and the virus titer was determined using the limited dilution
method. For each virus, two animals were sacriﬁced four days after
infection, and the lung was examined gross pathologically. Tissue
samples were harvested from the upper left and lower right lung lobe
and formalin-ﬁxed for further histopathological analysis. All animal
experiments were approved by the INRS Institutional Animal Care and
Use Committee.
Histopathology and immunohistochemistry
Formalin-ﬁxed lung tissue was parafﬁn-embedded and 5 μm tissue
sections were cut. The slides were deparafﬁnized and either H&E-
stained for morphological evaluation or further processed for immuno-
histochemistry. Towards this, the slides were ﬁrst incubated with a
polyclonal goat-anti inﬂuenza A antibody (OBT1551, AbD Serotec) that
detected the H1N1 and H3N2 subtypes used at a 1:300 dilution.
Inﬂuenza-infected cells were visualized using the Vectastain ABC Kit
for goat IgG (Vector Laboratories) in combination with the substrate
diaminobenzidine (Sigma), and counterstained with hematoxylin
(EMD).
Cytokine mRNA quantiﬁcation
Immediately after collection, 200 μl of nasal wash ﬂuid was mixed
with 1 ml Saliva Reagent (Qiagen) and stored at −20 °C. The RNA was
isolated following the instructions of the RNeasy Protect Saliva Mini
kit (Qiagen). Cytokine and GAPDH mRNAs were quantiﬁed using the
QuantiTect SYBR Green RT-PCR kit (Qiagen). For each reaction, 10 ng of
RNA was mixed with 0.5 μM of each primer and the appropriate
amount of PCR reagents following the manufacturer's instructions.
The primers used for IFNα, IFNγ, TNFα, and IL-6 were published
previously (Svitek and von Messling, 2007). To detect ferret IL-8, the
ﬁrst set of primers was based on conserved regions of the respective
canine and feline genes. Using these primers, a fragment of ferret IL-8
was ampliﬁed from RNA isolated from canine distemper virus-
infected ferret alveolar epithelial cells and sequenced (GenBank
accession no.: EU477256). Based on this ferret sequence the following
real-time PCR primers were selected using the PrimerQuest program
(IDT): IL8-S 5′-TGC TTT CTG CAG TTC TGT GTG AGC-3′, and IL8-AS 5′-
ATG TGG GCC ACT GTC AAT CAC TCT-3′.
The real-time PCR was performed in a RG-3000A thermocycler
(Rotor-Gene), using the following protocol: reverse transcription at
50 °C for 30min, denaturation at 95 °C for 15min, followed by45 cycles
of 95 °C for 5 s, 58 °C for 15 s, and 72 °C for 25 s, and a melting curve
analysis to conﬁrm reaction speciﬁcity. Each experiment was
performed in duplicate, and repeated if values varied more than 10%.
Due to the limited amount of RNA available, samples that displayed
more than 10% variability after four experiments had to be excluded
from the analysis. The fold change ratios between experimental and
control samples for each gene were calculated and normalized against
GAPDH using the ΔΔCt method (Schmittgen et al., 2000).
Since the nasal wash of non-infected animals contained only few
cells, 1 ml of nasal wash ﬂuid was collected prior to infection, and the
cells were concentrated by centrifugation before adding the Saliva
Reagent. If a cytokine was not detected or too weak in the pre-
infection sample of an animal, the average value of ﬁve representative
pre-infection samples was used for the calculation of fold mRNA
expression change. The same average values were used in all cases.
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